Mitochondria-Targeted MPDA Nanosystem Co-Delivering Evodiamine and IR820 for Chemo-Photothermal Therapy of Hepatocellular Carcinoma.

Int J Nanomedicine · 2026 · PMC13248977 · PMID 42273175

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

At the same time, the expression of the antioxidant enzyme GPX4 showed a decreasing trend across EVO-2, EVO-2 + L, EVO-3, and EVO-3 + L groups, with all exhibiting significant differences from the Con group ( Figure 6C and D ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.